Modern, AI-powered clinical trial software platform.
Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC.
Storm Stillman
Co-founder and CEO of Luminist Labs (Acquired by DiscernDx) Currently CEO @ Curebase (S18)
Storm Stillman
Co-founder and CEO of Luminist Labs (Acquired by DiscernDx) Currently CEO @ Curebase (S18)
LinkedIn